CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/06/2023
Back to search
Official data from USPTO
I-MED PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
77
Latest update
03/06/2023
Trademark type
Combined
Nice classes
3, 5, 10
Filing date
07/01/2017
Registration date
10/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2022
Last transaction
10/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
12/31/2017
First use in commerce
12/31/2017
Drawing code
3
Owner type
03
Owner location
Dollard-des Ormeaux, CA
Examiner
CALLOWAY, CHRISTINA DENISE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "I-MED" positioned above the wording "PHARMA" and a stylized liquid drop design to the left to the wording.
Holders and representatives
Holders
I-MED PHARMA INC.
Representatives
James R Menker HOLLEY & MENKER, PA
Technical classification
Nice Classes
Class 3Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
eye gels; non-medicated eye washes
Class 5
Pharmaceutical preparations for use in ophthalmology; eye drops; medicated eye washes; cleaninghydrating and disinfecting solutions for medical instruments for ophthalmic use; ophthalmic pharmaceutical preparationssolutions for use in surgery; nutritional supplements for the health of the eye
Class 10
Surgical instruments and devices; Eye care productseye droppers for human and veterinary use and eye protectors for therapeutic use for treating dry eyes for human and veterinary use; surgical instruments; Prosthetic intraocular lens implants; medical devices for diagnosing ophthalmic diseasesdisorders and conditions; medical devices for measuring intraocular pressure; medical devices for measuring osmolarity of eye tissues; surgical devices and machines for performing ophthalmic surgery; operating room customized surgical packs containing surgical instruments and surgical supplies for ophthalmic surgery
Publications
History of USPTO decisions and trademark events.
77 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/06/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/14/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2022
PUBO
PUBLISHED FOR OPPOSITION
07/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/15/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/31/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/11/2022
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
04/11/2022
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
04/11/2022
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
04/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/09/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/17/2021
GNFR
FINAL REFUSAL E-MAILED
10/17/2021
CNFR
FINAL REFUSAL WRITTEN
10/17/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/13/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/12/2021
GNRT
NON-FINAL ACTION E-MAILED
09/12/2021
CNRT
NON-FINAL ACTION WRITTEN
09/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/23/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/25/2021
GNRT
NON-FINAL ACTION E-MAILED
02/25/2021
CNRT
NON-FINAL ACTION WRITTEN
02/25/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2021
ALIE
ASSIGNED TO LIE
02/18/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/09/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
02/09/2021
IUAA
USE AMENDMENT ACCEPTED
02/07/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
01/14/2021
IUAF
USE AMENDMENT FILED
01/14/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/13/2021
DMCC
DATA MODIFICATION COMPLETED
12/23/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/12/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/12/2020
CNSL
SUSPENSION LETTER WRITTEN
11/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/27/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/27/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/08/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/21/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/21/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/21/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/15/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/11/2018
GNSL
LETTER OF SUSPENSION E-MAILED
05/11/2018
CNSL
SUSPENSION LETTER WRITTEN
05/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2018
ALIE
ASSIGNED TO LIE
04/19/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2017
GNRT
NON-FINAL ACTION E-MAILED
10/16/2017
CNRT
NON-FINAL ACTION WRITTEN
10/16/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/29/2017
GNRT
NON-FINAL ACTION E-MAILED
09/29/2017
CNRT
NON-FINAL ACTION WRITTEN
09/29/2017
DOCK
ASSIGNED TO EXAMINER
09/27/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2017
NWAP
NEW APPLICATION ENTERED
07/05/2017
Continuous trademark protection
Get notified about every new filing that threatens I-MED PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.